The Medtronic RESOLUTE US Clinical Trial (R-US)

Trial ID or NCT#

NCT00726453

Status

not recruiting iconNOT RECRUITING

Purpose

The objective of the study is to assess the safety and effectiveness of the Resolute Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm.

Investigator(s)

Alan Yeung, MD

View on ClinicalTrials.gov